MACK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (8 geg. 2024 @ 23:00):

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Stats
Dzisiejszy wolumen	144 267
Średni wolumen	145 854
Kapitalizacja rynkowa	218.41M
EPS	$0 ( 2024-05-02 )
Następna data zysków	( $0 ) 2024-08-01
Last Dividend	$0.500 ( 2019-12-13 )
Next Dividend	$0 ( N/A )
P/E	-187.87
ATR14	$0.00400 (0.03%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-28	Andersen Eric	Buy	857	Common Stock
2023-12-26	Andersen Eric	Buy	48 693	Common Stock
2023-12-07	Andersen Eric	Buy	76 384	Common Stock
2023-12-07	Andersen Eric	Buy	24 666	Common Stock
2023-11-17	Andersen Eric	Buy	235	Common Stock

INSIDER POWER
99.83
Last 100 transactions
Buy: 1 159 920 \| Sell: 7 000

Wolumen Korelacja

Długi: 0.00 (neutral)

Krótki: 0.47 (neutral)

Signal:(39.86) Neutral

Merrimack Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
TA	0.984
IIN	0.983
ATCX	0.983
ECHO	0.98
MOR	0.973
EZPW	0.957
META	0.947
PNT	0.947
KRTX	0.946
TESS	0.945

10 Najbardziej negatywne korelacje
SJ	-0.966
BIOL	-0.964
CHTR	-0.961
MRBK	-0.96
UTMD	-0.955
WTER	-0.951
CYXT	-0.948
GNPX	-0.946
LBRDK	-0.945
LBRDA	-0.945

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Merrimack Pharmaceuticals Korelacja - Waluta/Towar

0.22
( neutral )

0.25
( neutral )

0.00
( neutral )

-0.17
( neutral )

Merrimack Pharmaceuticals Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-0.0826

FY	2023
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-0.0826

FY	2022
Przychody:	$0
Zysk brutto:	$-445 000 (0.00 %)
EPS:	$-0.110

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.180

Financial Reports:

No articles found.

Merrimack Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Merrimack Pharmaceuticals Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$8.30	2017-05-30
Last Dividend	$0.500	2019-12-13
Next Dividend	$0	N/A
Payout Date	2019-12-23
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	$10.30	--
Avg. Dividend % Per Year	0.00%	--
Score	0.23	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2025-09-03)

$0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

0.23

Pay Frequency

Sporadic

Yearly Payout

Year	Amount	Yield
2017	$8.30	26.40%
2018	$0	0.00%
2019	$1.997	62.60%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.0524	1.200	-1.746	-2.10	[0 - 0.3]
returnOnEquityTTM	-0.0531	1.500	-1.701	-2.55	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	43.50	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	42.80	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	13.58	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.106	2.00	-0.0354	-0.0708	[0 - 30]
freeCashFlowPerShareTTM	-0.106	2.00	-0.0531	-0.106	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				0.695

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-214.43	1.000	-10.00	0	[1 - 100]
returnOnEquityTTM	-0.0531	2.50	-1.093	-2.55	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.106	2.00	-0.0354	-0.106	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.106	2.00	-0.0354	-0.0708	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.537

Merrimack Pharmaceuticals